Literature DB >> 31988084

Opportunistic screening versus usual care for diagnosing atrial fibrillation in general practice: a cluster randomised controlled trial.

Femke Kaasenbrood1, Monika Hollander1, Steven Hm de Bruijn1, Carlijn Pe Dolmans1, Robert G Tieleman2, Arno W Hoes1, Frans H Rutten1.   

Abstract

BACKGROUND: Atrial fibrillation (AF) increases the risk of stroke, heart failure, and all-cause mortality. AF may be asymptomatic and therefore remain undiagnosed. Devices such as single-lead electrocardiographs (ECGs) may help GPs to diagnose AF. AIM: To investigate the yield of opportunistic screening for AF in usual primary care using a single-lead ECG device. DESIGN AND
SETTING: A clustered, randomised controlled trial among patients aged ≥65 years with no recorded AF status in the Netherlands from October 2014 to March 2016.
METHOD: Fifteen intervention general practices used a single-lead ECG device at their discretion and 16 control practices offered usual care. The follow-up period was 1 year, and the primary outcome was the proportion of newly diagnosed cases of AF.
RESULTS: In total, 17 107 older people with no recorded AF status were eligible to participate in the study. In the intervention arm, 10.7% of eligible patients (n = 919) were screened over the duration of the study year. The rate of newly diagnosed AF was similar in the intervention and control practices (1.43% versus 1.37%, P = 0.73). Screened patients were more likely to have comorbidities, such as hypertension (60.0% versus 48.7%), type 2 diabetes (24.3% versus 18.6%), and chronic obstructive pulmonary disease (11.3% versus 7.4%), than eligible patients not screened in the intervention arm. Among patients with newly diagnosed AF in intervention practices, 27% were detected by screening, 23% by usual primary care, and 50% by a medical specialist or after stroke/transient ischaemic attack.
CONCLUSION: Opportunistic screening with a single-lead ECG at the discretion of the GP did not result in a higher yield of newly detected cases of AF in patients aged ≥65 years in the community than usual care. For higher participation rates in future studies, more rigorous screening methods are needed. © British Journal of General Practice 2020.

Entities:  

Keywords:  atrial fibrillation; diagnosis; electrocardiograph; older people; pulse; screening

Mesh:

Year:  2020        PMID: 31988084      PMCID: PMC6988680          DOI: 10.3399/bjgp20X708161

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  18 in total

1.  Clinical outcome of patients who develop PAF after CABG surgery.

Authors:  P R Kowey; D Stebbins; L Igidbashian; S M Goldman; F P Sutter; S J Rials; R A Marinchak
Journal:  Pacing Clin Electrophysiol       Date:  2001-02       Impact factor: 1.976

2.  Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial.

Authors:  David A Fitzmaurice; F D Richard Hobbs; Sue Jowett; Jonathon Mant; Ellen T Murray; Roger Holder; J P Raftery; S Bryan; Michael Davies; Gregory Y H Lip; T F Allan
Journal:  BMJ       Date:  2007-08-02

3.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas; Stefan Agewall; John Camm; Gonzalo Baron Esquivias; Werner Budts; Scipione Carerj; Filip Casselman; Antonio Coca; Raffaele De Caterina; Spiridon Deftereos; Dobromir Dobrev; José M Ferro; Gerasimos Filippatos; Donna Fitzsimons; Bulent Gorenek; Maxine Guenoun; Stefan H Hohnloser; Philippe Kolh; Gregory Y H Lip; Athanasios Manolis; John McMurray; Piotr Ponikowski; Raphael Rosenhek; Frank Ruschitzka; Irina Savelieva; Sanjay Sharma; Piotr Suwalski; Juan Luis Tamargo; Clare J Taylor; Isabelle C Van Gelder; Adriaan A Voors; Stephan Windecker; Jose Luis Zamorano; Katja Zeppenfeld
Journal:  Europace       Date:  2016-08-27       Impact factor: 5.214

Review 4.  Atrial fibrillation after cardiac surgery.

Authors:  W H Maisel; J D Rawn; W G Stevenson
Journal:  Ann Intern Med       Date:  2001-12-18       Impact factor: 25.391

5.  Randomised trial of two approaches to screening for atrial fibrillation in UK general practice.

Authors:  Stephen Morgan; David Mant
Journal:  Br J Gen Pract       Date:  2002-05       Impact factor: 5.386

6.  A campaign for information and diagnosis of atrial fibrillation: "pulse week".

Authors:  Marcelo Sanmartín; Francisco Fraguela Fraga; Angel Martín-Santos; Pilar Moix Blázquez; Alba García-Ruiz; María Vázquez-Caamaño; Manuel Vilar
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2012-09-08

7.  Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention.

Authors:  Johan Engdahl; Lisbeth Andersson; Maria Mirskaya; Mårten Rosenqvist
Journal:  Circulation       Date:  2013-01-23       Impact factor: 29.690

8.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

Review 9.  Accuracy of methods for detecting an irregular pulse and suspected atrial fibrillation: A systematic review and meta-analysis.

Authors:  Jaspal S Taggar; Tim Coleman; Sarah Lewis; Carl Heneghan; Matthew Jones
Journal:  Eur J Prev Cardiol       Date:  2015-10-13       Impact factor: 7.804

10.  Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation.

Authors:  R G Tieleman; Y Plantinga; D Rinkes; G L Bartels; J L Posma; R Cator; C Hofman; R P Houben
Journal:  Europace       Date:  2014-05-13       Impact factor: 5.214

View more
  9 in total

1.  2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society.

Authors:  Niraj Varma; Iwona Cygankiewicz; Mintu P Turakhia; Hein Heidbuchel; Yu-Feng Hu; Lin Yee Chen; Jean-Philippe Couderc; Edmond M Cronin; Jerry D Estep; Lars Grieten; Deirdre A Lane; Reena Mehra; Alex Page; Rod Passman; Jonathan P Piccini; Ewa Piotrowicz; Ryszard Piotrowicz; Pyotr G Platonov; Antonio Luiz Ribeiro; Robert E Rich; Andrea M Russo; David Slotwiner; Jonathan S Steinberg; Emma Svennberg
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-02-12

2.  2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society.

Authors:  Niraj Varma; Iwona Cygankiewicz; Mintu P Turakhia; Hein Heidbuchel; Yufeng Hu; Lin Yee Chen; Jean-Philippe Couderc; Edmond M Cronin; Jerry D Estep; Lars Grieten; Deirdre A Lane; Reena Mehra; Alex Page; Rod Passman; Jonathan P Piccini; Ewa Piotrowicz; Ryszard Piotrowicz; Pyotr G Platonov; Antonio Luiz Ribeiro; Robert E Rich; Andrea M Russo; David Slotwiner; Jonathan S Steinberg; Emma Svennberg
Journal:  Cardiovasc Digit Health J       Date:  2021-01-29

3.  Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled Trial.

Authors:  Steven A Lubitz; Steven J Atlas; Jeffrey M Ashburner; Ana T Trisini Lipsanopoulos; Leila H Borowsky; Wyliena Guan; Shaan Khurshid; Patrick T Ellinor; Yuchiao Chang; David D McManus; Daniel E Singer
Journal:  Circulation       Date:  2022-03-02       Impact factor: 29.690

4.  Detection of atrial fibrillation in primary care with radial pulse palpation, electronic blood pressure measurement and handheld single-lead electrocardiography: a diagnostic accuracy study.

Authors:  Nicole Verbiest-van Gurp; Steven B Uittenbogaart; Wim A M Lucassen; Petra M G Erkens; J André Knottnerus; Bjorn Winkens; Henri E J H Stoffers; Henk C P M van Weert
Journal:  BMJ Open       Date:  2022-06-29       Impact factor: 3.006

5.  Validating risk models versus age alone for atrial fibrillation in a young Dutch population cohort: should atrial fibrillation risk prediction be expanded to younger community members?

Authors:  Jelle C L Himmelreich; Ralf E Harskamp; Bastiaan Geelhoed; Saverio Virdone; Wim A M Lucassen; Ron T Gansevoort; Michiel Rienstra
Journal:  BMJ Open       Date:  2022-02-16       Impact factor: 2.692

6.  Natural Language Processing to Improve Prediction of Incident Atrial Fibrillation Using Electronic Health Records.

Authors:  Jeffrey M Ashburner; Yuchiao Chang; Xin Wang; Shaan Khurshid; Christopher D Anderson; Kumar Dahal; Dana Weisenfeld; Tianrun Cai; Katherine P Liao; Kavishwar B Wagholikar; Shawn N Murphy; Steven J Atlas; Steven A Lubitz; Daniel E Singer
Journal:  J Am Heart Assoc       Date:  2022-07-29       Impact factor: 6.106

7.  Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial.

Authors:  Steven B Uittenbogaart; Nicole Verbiest-van Gurp; Wim A M Lucassen; Bjorn Winkens; Mark Nielen; Petra M G Erkens; J André Knottnerus; Henk C P M van Weert; Henri E J H Stoffers
Journal:  BMJ       Date:  2020-09-16

8.  Biomarkers associated with rhythm status after cardioversion in patients with atrial fibrillation.

Authors:  Pascal B Meyre; Stefanie Aeschbacher; Steffen Blum; Gian Voellmin; Peter M Kastner; Elisa Hennings; Beat A Kaufmann; Michael Kühne; Stefan Osswald; David Conen
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

9.  Detection of occult atrial fibrillation with 24-hour ECG after cryptogenic acute stroke or transient ischaemic attack: A retrospective cross-sectional study in a primary care database in Israel.

Authors:  Ori Liran; Tamar Banon; Alon Grossman
Journal:  Eur J Gen Pract       Date:  2021-12       Impact factor: 1.904

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.